Tatva Chintan Pharma Chem Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The promoter of Tatva Chintan Pharma Chem Limited, Chintan Nitinkumar Shah, has submitted a declaration confirming that neither he nor any persons acting in concert (including 16 other promoter group entities such as HUFs, family members, and group companies) created any encumbrance (pledge) on the company's shares during the Financial Year ended 31 March 2026. This is a negative declaration under SEBI's substantial acquisition regulations, meaning the filing confirms the absence of a specific event rather than reporting one. The disclosure covers the entire promoter group including entities like Premier Solution Private Limited, Marvel Indenting Private Limited, and others listed.
This is a neutral-to-positive filing for shareholders as it confirms promoters have not pledged their shares, which removes risk of forced share sales that could depress the stock price. No immediate impact on the stock.